Inventor · disambiguated record
Eva Steiness
Also filed as: STEINESS EVA
4 granted patents·5 pending applications·50 citations·filing 2003–2023
67Inventor score
Top patents by PatentIndex Score
9 records- 0189US7153822B2Compositions and methods for modulating connexin hemichannelsWYETH CORP·Filed 2003·Granted Dec 26, 2006·50 cites·4 claims
- 0261US12378294B2IL-4 derived peptides for use in the treatment of obesitySERODUS APS·Filed 2023·Granted Aug 5, 2025·0 cites·2 claims
- 0358US12440535B2IL-4 derived peptide fragments for use in the treatment of diabetic nephropathySERODUS APS·Filed 2023·Granted Oct 14, 2025·0 cites·1 claims
- 0456US12083097B2Dual TNFR1 antagonists and TNER2 agonists for use in renal diseasesSERODUS AS·Filed 2021·Granted Sep 10, 2024·0 cites·9 claims
- 0556US2009088369A1Glp-1 and methods for treating diabetesZEALAND PHARMA AS·Filed 2008·Application pending·0 cites
- 0651US2014187483A1Glp-1 and methods for treating diabetesZEALAND PHARMA AS·Filed 2014·Application pending·0 cites
- 0749US2007042964A1Compositions and methods for modulating connexin hemichannelsWYETH CORP·Filed 2006·Application pending·0 cites
- 0845US2006057137A1Glp-1 and methods for treating diabetesSTEINESS EVA·Filed 2003·Application pending·0 cites
- 0944US2024216464A1Il1ra derived peptides for treatment of diabetic nephropathySERODUS APS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eva Steiness files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →